Steve Lufkin is the founder of SeLux Diagnostics. SeLux Diagnostics has raised $78M in total funding. Latest round: Series B. Backed by RA Capital Management.
Steve Lufkin is the Chief Executive Officer of SeLux Diagnostics, a Boston-based biotech startup. He leads the commercialization of the SeLux NGP System in the United States and serves on the company's Board of Directors. Lufkin has overseen significant funding milestones for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library